Fig. 1From: Endovenous laser ablation versus mechanochemical ablation with ClariVein® in the management of superficial venous insufficiency (LAMA trial): study protocol for a randomised controlled trialStudy flow chart. The total target sample size is 140, which will be randomised to endovenous laser ablation (n = 70) or mechanochemical ablation (n = 70)Back to article page